LitCovid-sample-Enju  

PMC:7205724 / 172-374 JSONTXT 10 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T24 9-10 IN denotes •
T25 12-16 NNP denotes IVIG
T26 16-17 -COMMA- denotes ,
T27 18-26 VBN denotes combined
T28 27-31 IN denotes with
T29 32-45 NN denotes moderate-dose
T30 46-48 IN denotes of
T31 49-64 NNS denotes corticosteroids
T32 64-65 -COMMA- denotes ,
T33 66-71 MD denotes might
T34 72-79 VB denotes improve
T35 80-87 NN denotes patient
T36 88-96 NNS denotes outcomes
T37 98-99 PDT denotes •
T38 101-104 DT denotes The
T39 105-108 NN denotes use
T40 109-111 IN denotes of
T41 112-127 NNS denotes corticosteroids
T42 128-133 MD denotes might
T43 134-144 VB denotes accelerate
T44 145-153 NN denotes recovery
T45 154-158 IN denotes from
T46 159-167 NN denotes COVID-19
T47 169-170 PDT denotes •
T48 172-174 DT denotes No
T49 175-185 VBN denotes controlled
T50 186-194 JJ denotes clinical
T51 195-201 NNS denotes trials
R20 T25 T24 arg1Of IVIG,•
R21 T25 T26 arg1Of IVIG,","
R22 T25 T27 arg2Of IVIG,combined
R23 T27 T28 arg1Of combined,with
R24 T29 T28 arg2Of moderate-dose,with
R25 T29 T30 arg1Of moderate-dose,of
R26 T31 T30 arg2Of corticosteroids,of
R27 T34 T32 arg1Of improve,","
R28 T25 T33 arg1Of IVIG,might
R29 T34 T33 arg2Of improve,might
R30 T25 T34 arg1Of IVIG,improve
R31 T36 T34 arg2Of outcomes,improve
R32 T36 T35 arg1Of outcomes,patient
R33 T39 T37 arg1Of use,•
R34 T39 T38 arg1Of use,The
R35 T39 T40 arg1Of use,of
R36 T41 T40 arg2Of corticosteroids,of
R37 T39 T42 arg1Of use,might
R38 T43 T42 arg2Of accelerate,might
R39 T39 T43 arg1Of use,accelerate
R40 T44 T43 arg2Of recovery,accelerate
R41 T44 T45 arg1Of recovery,from
R42 T46 T45 arg2Of COVID-19,from
R43 T51 T47 arg1Of trials,•
R44 T51 T48 arg1Of trials,No
R45 T51 T49 arg2Of trials,controlled
R46 T51 T50 arg1Of trials,clinical